Indeed, all the CATs-treated FASN+ HAP1 populations reached a long-term equilibrium at CIs between 0.5 and 1 that may reflect the limited capacity of CATs to kill all the target FASN+ cancer cells regardless of the E:T ratio employed. This evidence concerns the gene FASN and cancer.